TPX2 and cancer: The first described PPI inhibitor was Withanone, a natural compound that blocks intermolecular hydrophobic interactions between TPX2 and AurkA involved in the formation of the complex, hindering its functionality and impairing mitotic spindle organisation in MCF7 cancer cells [114].